Sarcoma trials in South Korea

In South Korea 17 Also abroad 605

17 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Where
Busan, Daegu, Daejeon, Gyeonggi-do, Incheon, Jeollanam-do, Seongnam-si, Seoul
Age
18 years and over
People
400 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01
Phase 3Taking people
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Where
Incheon, Seoul
Age
18 years and over
People
428 worldwide
Run by
NRG Oncology
See details and how to joinNCT05646316
Phase 2Taking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Jongno -Gu, Seoul
Age
18 years and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Seoul
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 3Taking people
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Where
Bupyeong-gu, Daegu, Hwasun, Incheon, Junggu, Seoul, Suwon, Yangsan
Age
18 years and over
People
348 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00
No phaseTaking people
Treatment Patterns and Survival Outcomes in High-Grade Osteosarcoma: A Multicenter Retrospective Study
Where
Goyang-si, Seoul
Age
12 years and over
People
400
Run by
MedPacto, Inc.
See details and how to joinNCT07878364
Phase 1/2Taking people
Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
Where
Gyeonggi-do, Seoul
Age
12 years and over
People
78 worldwide
Run by
MedPacto, Inc.
See details and how to joinNCT05588648
Phase 1/2Taking people
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Where
Seoul
Age
Up to 25 years
People
75 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00
Phase 1Taking people
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Where
Seoul
Age
18 years and over
People
150 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06644755
Phase 2Taking people
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Where
Seoul
Age
18 years and over
People
140 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07252739 · EU 2025-521939-36-00
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Cheongju-si, Hwasun-eup, Hwasun-gun, Seoul
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
Phase 2Taking people
Pemetrexed, Cisplatin With Soft Tissue Sarcoma
Where
Seoul
Age
19 years and over
People
164
Run by
Yonsei University
See details and how to joinNCT04605770
No phaseNot yet taking people in South Korea
Prospective Phase I/II Study Evaluating the Safety and Efficacy of Preoperative Carbon Ion Radiotherapy in Patients With Soft Tissue Sarcoma : The SARCOMA-01 Trial by the Severance sARCOma Multidisciplinary Team
Where
Seoul
Age
19 years and over
People
60
Run by
Yonsei University
See details and how to joinNCT07250334
Phase 2Taking people
Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma
Where
Seoul
Age
20 years to 80 years
People
116
Run by
Yonsei University
See details and how to joinNCT05679921
Phase 1/2Taking people
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Where
Seoul, Suwon
Age
18 years and over
People
358 worldwide
Run by
GI Innovation, Inc.
See details and how to joinNCT05824975
Phase 1/2Not yet taking people in South Korea
A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma
Where
Donggu
Age
2 years to 25 years
People
148 worldwide
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05590572
No phaseTaking people
REtroperitoneal SArcoma Registry: an International Prospective Initiative
Where
Seoul
Age
18 years and over
People
2,000 worldwide
Run by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT03838718